|
NZ220221A
|
|
A nasal spray container containing a pharmaceutical composition for treating the common cold or other rhinovirus infection
|
|
AU7251587A
|
|
Compositions for treating the symptoms of or preventing the common cold
|
|
EP0288632A1
|
|
Compositions for treating the symptoms of or preventing the common cold
|
|
US4689223A
|
|
Method of treating the symptoms of the common cold
|
|
US4532131A
|
|
Therapeutic compositions
|
|
CA1239095A
|
|
Therapeutic compositions containing a water-soluble bisulfite
|
|
DE3419686A1
|
|
Use of a composition with therapeutic activity
|
|
US4657764A
|
|
Treatment of arthritis and arthritic conditions with sulfites and bisulfites
|
|
GB8411024D0
|
|
Anthocyanidin compositions
|
|
GB8406544D0
|
|
Pyrethroid-containing pharmaceutical compositions
|
|
US4462988A
|
|
Treatment of arthritis with bisulfite
|
|
US4464357A
|
|
Treatment of epilepsy with bisulfite
|
|
GB8300102D0
|
|
Antithrombotic/antihypertensive treatment
|
|
GB8300130D0
|
|
Formulations using mucolytic action
|
|
CA1175749A
|
|
Antihypertension treatment
|
|
US4402946A
|
|
Antithrombotic treatment
|
|
US4400396A
|
|
Antithrombotic treatment with organic amine sulfites and bisulfites
|
|
US4401655A
|
|
Antithrombotic treatment with salts of sulfites and bisulfites
|
|
US4400397A
|
|
Antithrombotic treatment with quaternary ammonium sulfites and bisulfites
|
|
US4421743A
|
|
Antihypertension treatment
|
